ArticleCancer medicine2024

Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway.

Yasuhiro Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.